Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial-Reference-Cited by-同舟云学术

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial

Published:2020-01-10 Issue:7 Volume:109 Page:930-943
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Tomaniak Mariusz,Chichareon Ply,Klimczak-Tomaniak Dominika,Takahashi Kuniaki,Kogame Norihiro,Modolo Rodrigo,Wang Rutao,Ono Masafumi,Hara Hironori,Gao Chao,Kawashima Hideyuki,Rademaker-Havinga Tessa,Garg Scot,Curzen Nick,Haude Michael,Kochman Janusz,Gori Tommaso,Montalescot Gilles,Angiolillo Dominick J.,Capodanno Davide,Storey Robert F.,Hamm Christian,Vranckx Pascal,Valgimigli Marco,Windecker Stephan,Onuma Yoshinobu,Serruys Patrick W.,Anderson Richard

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-019-01586-9.pdf

Reference38 articles.

1. Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL, Investigators RR (2009) Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J 158(1):141–148.e141. https://doi.org/10.1016/j.ahj.2009.05.011

2. Capodanno D, Angiolillo DJ (2012) Antithrombotic therapy in patients with chronic kidney disease. Circulation 125(21):2649–2661. https://doi.org/10.1161/CIRCULATIONAHA.111.084996

3. Bonello L, Angiolillo DJ, Aradi D, Sibbing D (2018) P2Y12-ADP receptor blockade in chronic kidney disease patients with acute coronary syndromes. Circulation 138(15):1582–1596. https://doi.org/10.1161/CIRCULATIONAHA.118.032078

4. Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kim HS, Valgimigli M, Palmerini T, Stone GW (2017) Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors. Clin Res Cardiol 106(3):165–173. https://doi.org/10.1007/s00392-016-1035-4

5. Weidner K, Behnes M, Schupp T, Rusnak J, Reiser L, Taton G, Reichelt T, Ellguth D, Engelke N, Bollow A, El-Battrawy I, Ansari U, Hoppner J, Nienaber CA, Mashayekhi K, Weiss C, Akin M, Borggrefe M, Akin I (2019) Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest. Clin Res Cardiol 108(6):669–682. https://doi.org/10.1007/s00392-018-1396-y

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease;The American Journal of Medicine;2023-12

2. Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3);The American Journal of Cardiology;2023-09

3. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis;Kidney360;2023-08-01

4. P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention;Journal of Cardiovascular Development and Disease;2022-10-06

5. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28